×

RNS Number : 4107E

Plant Health Care PLC

28 October 2022

 

RNS

28 October 2022

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

Distribution agreement for commercial sales in Europe 

 

EDAF Selected as Distributor in Portugal

 

Plant Health Care®(AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, has signed an agreement for EDAF Unipessoal LDA ("EDAF") to become the exclusive distributor in Portugal for its proprietary PREtec-containing fertilizer, PREzym™, for use in fruit, vegetable and cereals crop production.

 

The Company expects to commence commercial sales of PREzym in the first half of 2023. Plant Health Care and EDAF have been working together since 2016 when EDAF became the exclusive distributor in Portugal of the Company's proprietary ProAct® plant health product. Today's announcement further strengthens the partnership and will help Plant Health Care fulfill its ambitious plans to grow its global footprint/market share across Europe.

 

Derived from natural proteins, PREtec is an environmentally friendly technology which stimulates crop growth and ability to withstand a variety of abiotic stresses to improve plant health and yield. PREtec is compatible with mainstream agricultural practices.

 

Plant Health Care continues to expand into new markets around the world and is growing its relationships with major global distribution partners. The Company is on track to achieve revenue of $30 million by 2025 through the launch of new products and continued organic business growth through current and future distributor relationships.

 

This announcement marks the first sales of PREtec-based products into Europe and supports farmers seeking to use more sustainable practices.  Europe is fast becoming one of the largest markets for sustainable biological products and PREtec-containing products will help produce higher crop yields locally to address the global food supply crisis.

 

Jeff Tweedy, CEO of Plant Health Care,  said: ‟Today's announcement marks a significant milestone for Plant Health Care and our ambitious plans to grow our global footprint/market share. I am excited for our first sales of the PREtec technology in Europe which has the potential to grow considerably and transform the European farming industry towards a sustainable future with better crops delivering a higher yield for thousands of farmers.  EDAF has proven to be a strong partner over the years, supporting the growth of PHC's products in Portugal.

 

Pedro Tavares, CEO of EDAF Unipessoal Lda,  said:"Plant Health Care is a reliable partner, with cutting-edge technology and always looking for sustainable solutions for an increasingly demanding market, which allows for differentiated and technologically advanced products. This agreement aligns with our strategy to supply an innovative and high-quality portfolio to our customers and is responsive to the increasing demand for sustainable solutions. EDAF, LDA and its technical team would like to thank Plant Health Care for all the trust placed in it to develop and commercialize PREtec in Portugal"

 

For further information, please contact:
 

Plant Health Care plc Jeff Tweedy, CEO	+1 919 926 1600
Cenkos Securities plc – Nomad & Broker Neil McDonald / Pete Lynch	+44 (0) 131 220 9771
SEC Newgate (Financial Communications) Robin Tozer / Richard Bicknell / George Esmond	+44 (0)7540 10666 [email protected]

 

 

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

 

About EDAF Unipessoal LDA

EDAF focuses on representing and developing innovative/non residue high quality products for the portuguese agricultural markets. By providing qualified technical assistance, EDAF offers innovative solutions to growers all year around.

 

Find out more at  www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

AGRFEUFWWEESEFS

Close

×

RNS Number : 7747D

Proton Motor Power Systems PLC

24 October 2022

 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information, as stipulated under the UK Market Abuse Regulation. With the publication of this announcement, this information is now considered to be in the public domain.

 

24 October 2022

 

Proton Motor Power Systems plc

("Proton Motor" or the "Company")

 

New production facility to significantly expand manufacturing capability

 

Proton Motor Power Systems plc (AIM: PPS), a leading designer, developer and producer of fuel cells and fuel cell electric hybrid engines with a zero-carbon footprint, announces that it has signed a fifteen-year lease agreement for a modern 13,500m2 facility (the "Facility") that will be used to substantially expand the Company's manufacturing, testing and development capacity.

 

Proton Motor has been developing its fuel cell technology since 1998 to be probably one of the leading fuel cells in industrial, long-lifetime markets. There is an increased political awareness that hydrogen and fuel cells will play a fundamental role to overcome the climate energy crisis and this is expected to lead to an increased demand for fuel cells. In anticipation of this increased demand for the Company's products, Proton Motor intends to increase its annual production capacity to 5,000 fuel cell hydrogen engines and up to 30,000 fuel cell stacks.

 

The Facility will supplement the Company's current 6,000m2 site in Puchheim, Germany, which will now become the development facility for stacks and hydrogen engines. The new Facility is located in the town of Fürstenfeldbruck, located c. 12km from Puchheim and is contained within the Munich metropolitan region. The Facility will be used for serial manufacturing and will also be the location of the Company's sales and marketing teams, as well as the maintenance and training centre.

 

The total land surface of the Facility is 25,700m2 and it contains over 13,500m2 of useable space, of which over 10,500m2 can be dedicated to production, testing and development. The remainder of the space will be devoted to office usage. This represents a seven-fold increase in the amount of space available for production when compared to the Company´s current premises.

 

Concurrently with the enhancement of production capacity, the Directors of Proton Power have determined that the Company will be enlarging the sales department in order to meet the anticipated increase in demand.

 

Dr. Faiz Nahab, Chief Executive Officer of Proton Motor, stated: "Hydrogen is the energy storage source of the future and awareness of this is increasing to a considerable extent both amongst the public and within industry. This creates a strong market-pull for associated technologies such as fuel cells. This is evidenced by discussions with existing customers for midterm batch orders. With this background, the additional space provided by the new Facility will give Proton Motor the required capacity to produce, test and deliver fuel cell hydrogen engines in line with this anticipated growing demand."

 

 

 

For further information:

 

Proton Motor Power Systems Plc
Dr Faiz Nahab, CEO
Helmut Gierse, Chairman
Roman Kotlarzewski, CFO	+49 (0) 173 189 0923
Antonio Bossi, Non-Executive Director
Investor relations:	www.protonpowersystems.com
inv[email protected]
Allenby Capital Limited
Nominated Adviser & Broker	+44 (0) 20 3328 5656
James Reeve / Vivek Bhardwaj

 

About Proton Motor Fuel Cell GmbH

 

Proton Motor has more than 20 years of experience in Power Solutions using CleanTech technologies such as hydrogen fuel cells, fuel cell and hybrid hydrogen engines with a zero carbon footprint.  Based in Puchheim near Munich, Proton Motor offers complete fuel cell and hybrid hydrogen engines  from a single source – from the development and production through the implementation of customized solutions.  The focus of Proton Motor is on back-to-base, for example, for mobile, marine and stationary solutions applications.  The product portfolio consists of base-fuel cell hydrogen engines, standard complete hydrogen engines, as well as customized hydrogen engines .

 

Proton Motor serves IT, Telecoms, public infrastructure and healthcare customers in Germany, Europe and Middle East with power supply solutions for DC and AC power demand.

 

Proton Motor Fuel Cell GmbH is a wholly owned subsidiary of Proton Motor Power Systems plc. The Company has been quoted on the AIM market of the London Stock Exchange since October 2006 (code: PPS).

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCBKDBPPBDDBKB

Close

×

RNS Number : 5550C

S-Ventures PLC

12 October 2022

 

12 October 2022

 

S-VENTURES PLC

("S-Ventures" or the "Company")

AQSE Ticker Code: SVEN

Market Rocket launches new full service offer

S-Ventures PLC, the Company investing in and growing exciting brands across the natural, wellness and food-tech category, is pleased to announce Market Rocket, the Amazon growth specialists owned by S-Ventures, has launched its new full service digital marketing and PR offer following the recent acquisition of two digital marketing agencies.

Since 2019, Market Rocket, has delivered transformative D2C business growth to more than 100 global industry leaders (including brands such as Calvin Klein, Tommy Hilfiger and JCB) across the Amazon ecosystem, earning the platform's SPN (Service Provider Network) accreditation, but will now offer clients a complete digital marketing and PR service.

Combining more than 50 years of experience in driving sales growth via Amazon, Market Rocket has now acquired strategic digital marketing specialists Mapped Marketing and award winning PPC and SEO agency Bugbear Marketing.

The deal, announced this month, positions Market Rocket as the ideal launch pad for big brands, founder-owned market-disruptors and start-ups alike to achieve business growth through specialist website development, SEO performance, on-trend social media engagement, digital marketing and PR, to add to its broad D2C and ecommerce expertise.

Market Rocket Founder and Managing Director, Matthew Peak, commented: "We firmly believe that amalgamating Market Rocket's proven ability to deliver ROI on Amazon with the specialist SEO, PPC, website design, and PR skills provided by the other agencies mean that these acquisitions will help us to create a truly unique offering to some of the world's largest brands and newest market-disruptors."

S-Ventures CEO, Scott Livingston, commented: "We are delighted with the progress Market Rocket has made with the latest acquisitions of two digital marketing agencies and subsequent new full service digital marketing and PR offering. Our focus on quality across our product range underpins our success and we look forward to further progress in the coming months."

www.marketrocket.co.uk

For further information, please contact:

The Company Robert Hewitt (Chief Financial Officer) Scott Livingston (Chief Executive Officer)	+44 (0) 1932 400 224
AQSE Corporate Adviser and Broker: VSA Capital Limited Andrew Raca – Corporate Finance Andrew Monk – Corporate Broking	+44 (0) 20 3005 5000
IFC Advisory (Financial PR) Graham Herring Tim Metcalfe Florence Chandler	+44 (0) 20 3934 6630

 

About S-Ventures

S-Ventures is listed on UK AQUIS Exchange (Ticker Code "SVEN"). The Company seeks to identify investment opportunities in the health & wellness, organic food and wellbeing sectors within the UK and Europe, adding value by providing capital and expertise to the target companies. The experience and operational skills of the Board led by Scott Livingston (CEO) are intended to act as an accelerator to smaller brands that have a solid foundation and platform but may lack the skills and capital. The main objectives are to cross-fertilise opportunities between the target companies and scale the individual entities and look for exit opportunities and/or synergistic collaborations through scaling we seek to create significant value for all stakeholders. Since listing on AQSE in September 2020, the Company has acquired significant interests in seven companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NEXMBBPTMTMBBLT

Close

×

RNS Number : 9412B

AMTE Power PLC

06 October 2022

 

Thursday 6 October 2022

 

AMTE POWER PLC

("AMTE Power", "AMTE" or the "Company")

AMTE Power agrees production contract with the UK Battery Industrialisation Centre for its Ultra High Power cells

 

Highlights:

·     Milestone achievement: framework contract signed with the UK Battery Industrialisation Centre ("UKBIC") to produce up to 60,000 Ultra High Power cells per year for the high power automotive and fuel cell electric vehicle markets

 

·     Ultra High Power automotive cell demonstrates a consistent six-minute full charge time in extensive trials

 

·     The contract with UKBIC starts in January 2023 for anticipated sales to customers in sufficient scale to allow them to progress to in-vehicle trials

 

·     Agreement is a key milestone to upscale production ahead of mass commercialisation plans as AMTE Power progresses towards its first MegaFactory in Dundee, Scotland, which is underpinned by the growing pipeline of potential business with opportunities of circa £240 million across the AMTE Power product range

 

AMTE Power moves to scale manufacturing at the UK Battery Industrialisation Centre

AMTE Power, the developer and manufacturer of lithium-ion and sodium-ion battery cells for specialist markets, announces that it has signed a contract to manufacture its Ultra High Power cells at UKBIC in Coventry to support the next phase of its commercialisation plans.  

This is a significant milestone for AMTE Power. Under the agreement the Company can request UKBIC to manufacture up to 60,000 of its Ultra High Power cells each year, over an initial term of 24 months.  This will enable AMTE Power to deliver its first Ultra High Power cells, in sufficient scale to allow customers to progress through to in-vehicle trials, as the industry transitions away from traditional fuels.

In August 2022, AMTE Power announced good progress in manufacturing trials for the Ultra High Power cell at UKBIC, with cells performing well against the Company's target specification when produced on UKBIC's commercial scale equipment.  In particular, the Ultra High Power cells' low internal resistance supports exceptional power delivery and very fast charging, with current testing demonstrating a full charge in six minutes.

Ramping up production of the Ultra High Power cells at UKBIC is due to start from January 2023, generating initial revenues for the Company and enabling the business to meet growing demand from within the automotive sector principally for high performance Electric Vehicles ("EVs") and Fuel Cell Electric Vehicles ("FCEVs"). AMTE Power has existing non-binding memoranda of understanding in place with key automotive partners Cosworth, Viritech and MAHLE Powertrain, in addition to development agreements with Sprint Power, Eltrium and BMW.  

The use of UKBIC to manufacture cells is a key milestone to upscale production ahead of mass commercialisation plans as AMTE Power progresses towards its first MegaFactory in Dundee, Scotland. This agreement will ensure products can be delivered to customers in advance of the opening of its planned MegaFactory, which is underpinned by the growing pipeline of potential business with opportunities of circa £240 million across the AMTE Power product range.

Commenting on the contract, Kevin Brundish, CEO, AMTE Power, said:

"Having already secured significant early interest in our Ultra High Power cell from major automotive partners, this contract will enable us to bring our products to market sooner while we progress our own MegaFactory.

"This new phase in our journey builds on the partnership that we've established with UKBIC through cell development. It is testament to the investment that the UK Government has made in this market-leading battery manufacturing and scale-up facility that we are now able to put that development work into practice with the first production contract at UKBIC to get cells into customers' hands as we power the energy transition."

Jeff Pratt, Managing Director, UK Battery Industrialisation Centre, added:

"We're delighted to be entering into this landmark agreement with AMTE Power to transfer their design into UKBIC and then manufacture their next generation Ultra High Power cells at volume, allowing us to further support the company's significant commercialisation plans. Advanced battery cells being manufactured at volume in the UK are a vital component of ensuring the UK prospers from the energy transition towards Net Zero. This latest agreement – our biggest to date – is further demonstration of the unique value of UKBIC which, since being opened just over a year ago, is already delivering incredibly successful outcomes for the UK with customers like AMTE."

Jackie Doyle-Price, Minister for Industry said: 

"Batteries are the foundation of the industries of the future, from electric vehicles to renewables, and building a domestic supply chain for them is central to our plans to grow the economy, create jobs and bolster energy security.

"This collaboration between two government-backed partners will see AMTE's battery production ambitions take the next step, and help the UK seize on the opportunities this technology presents." 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

ENDS

Enquiries:
AMTE Power plc	Tel: +44 (0)1847 867 200
Kevin Brundish (Chief Executive Officer)
James Hobson (Chief Financial Officer)
WH Ireland Limited (NOMAD and Joint Broker)	Tel: +44 (0)207 220 1666
Chris Fielding / James Bavister / Ben Good
Panmure Gordon (UK) Limited   (Joint Broker)	Tel: +44 (0)207 886 2500
John Prior / Harriette Johnson (Corporate Finance) James Sinclair-Ford Hugh Rich (Corporate Broking)
Camarco (Financial PR)	Tel: +44 (0)20 3757 4992
Ginny Pulbrook / Rosie Driscoll

 

Notes to Editors:

AMTE Power was founded in 2013 and is a leading developer and manufacturer of lithium-ion and sodium-ion battery cells for specialist markets. In March 2021, the Company was admitted to trading on the AIM market of the London Stock Exchange. The Company is focused on launching a series of next generation battery cells based on new chemistries and cell structures that are designed to solve key problems in power delivery, energy performance, and safety. These new products are targeted at a range of specialist markets including the electric vehicle industry and energy storage sector. 

 

AMTE Power's purpose-built cell manufacturing facility in Thurso, Scotland has the second largest cell manufacturing capacity in the UK and the Company also has a product development team based in Oxford. AMTE's proposed state-of-the-art MegaFactory in Dundee, Scotland is expected to be operational and in production by Q3 2025 and will be capable of producing over 25,000 high added value batteries per day enabling the Company to rapidly scale up cell production.

 

For further information visit the Company's website:  www.amtepower.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

CNTBKPBNABDDKKK

Close

×

RNS Number : 6141B

N4 Pharma PLC

04 October 2022

 

 

4 October 2022

 

N4 Pharma Plc

("N4 Pharma" or the "Company")

Double siRNA Testing Update

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to announce successful in vitro testing of Nuvec® loaded with two small interfering RNA (siRNA) probes.

 

On 14 September 2022, the Company announced a strategic update highlighting its intention to focus its further development work on multiple loaded siRNA on Nuvec®.

T he Company has now completed initial in vitro testing of Nuvec® loaded with two generic siRNA probes, GFP (Green Fluorescent protein) and EHMT-2 (Euchromatic Histone Lysine Methyltransferase 2 ) at the same time. The siRNA probes were loaded onto Nuvec® in equal amounts, at a concentration previously shown to be active. Testing demonstrated that both siRNA probes when loaded onto Nuvec® were able to significantly silence their respective targets.

 

 

Nigel Theobald, Chief Executive Officer of the Company, commented :

 

"Showing that Nuvec® loaded with two generic siRNA probes still achieves significant silencing of their respective genes is validation for us to now begin the further work that we announced on 14 September with EGFR and BCl-2 in a PC9 lung cancer model.

 

"Achieving the initial successful testing of Nuvec ® with the generic GFP and EHMT-2 siRNA will also allow us to commence commercial outreach discussions which will only be further strengthened by the results from the new work we are undertaking ."

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which has been incorporated into UK law by the European Union (Withdrawal) Act 2018.  

 

 

Enquiries:

 

N4 Pharma Plc Nigel Theobald, CEO Luke Cairns, Executive Director	Via IFC Advisory
SP Angel Corporate Finance LLP Nominated Adviser and Joint Broker Matthew Johnson/Caroline Rowe (Corporate Finance) Vadim Alexandre/Rob Rees (Corporate Broking)	Tel: + 44 (0)20 3470 0470
IFC Advisory Limited Financial PR Graham Herring Zach Cohen	Tel: +44 (0)20 3934 6630

 

 

About N4 Pharma

N4 Pharma is a specialist pharmaceutical company developing a novel delivery system for cancer and vaccine treatments using its unique silica nanoparticle delivery system called Nuvec®.

N4 Pharma's business model is to partner with companies developing novel antigens for cancer and vaccine treatments to use Nuvec® as the delivery vehicle to get their antigen into cells to express the protein needed for the required immunity. As these products progress through pre clinical and clinical programs, N4 Pharma will seek to receive up front payments, milestone payments and ultimately royalty payments once products reach the market.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCMJBATMTJMBTT

Close

×

RNS Number : 6037B

S-Ventures PLC

04 October 2022

 

4 October 2022

 

S-VENTURES PLC

("S-Ventures" or the "Company")

AQSE Ticker Code: SVEN

New contract wins

S-Ventures PLC, the Company investing in and growing exciting brands across the natural, wellness and food-tech category, is pleased to announce new contract wins from its Pulsin, Purely, Ohso and Livia's product ranges.

ASDA has recently partnered with S-Ventures and has given Pulsin branded space within their brand partnership programme to showcase the brand in six ASDA flagship stores.

This follows the launch of the Pulsin Keto range in the Health & Wellbeing fixture in 200 Morrison stores in Spring of this year.

In Holland & Barrett UK Stores, Pulsin has increased its store distribution on their protein powders range by over 2,000 distribution points, which goes live this month. They also launched the latest flavoured protein powder, the Vanilla & Faba protein powder in over 300 stores.

As well as supporting Pulsin, the food team at Holland & Barrett UK have also listed the Purely brand, listing the 28g impulse bags at front of store locations.

Further afield, Holland & Barrett Benelux have really supported S-Ventures, with the Pulsin Orange Keto Bars now listed within stores, as well as the 75g Purely sharing bags now available within the food section.

Co-op has been revamping its ranges in their Healthy Snacking fixtures and will see an increase in Pulsin distribution of their Keto range as well as launching a Pulsin brownie range.

In WH Smiths:

· Purely 75g recently went live in over 100 travel sites;

· Pulsin went live in February 2022 with the brownie range featuring within their "meal deal" solution; and

· OhSo went live in May featuring Ohso's "block" chocolate fixture.

 

Epicurum Wholesale has launched Pulsin, Purely & Livias which are now all live.

At Blakemore/The Vegan Store, it is in the process of going live across all S-Ventures brands.

Pulsin is now live within the two major retailers, S-Ok and more recently Kesko, in Finland.

Easyjet has selected Livia's Nugglets for its inflight menu for the Summer / Autumn 2022 period.

Valli Forecourts agreed to go live with Pulsin in their forecourts in the Summer 2022, offering a range of Keto Bars, Protein Bars and Brownies.

CEO, Scott Livingston, Statement:

"These significant contract wins with major brand names, demonstrate the rapid progress S-Ventures is making establishing itself in the UK and in Europe. Our focus on quality across our product range underpins our success and we look forward to further progress in the coming months."

 

For further information, please contact:

The Company Robert Hewitt (Chief Financial Officer) Scott Livingston (Chief Executive Officer)	+44 (0) 1932 400 224
AQSE Corporate Adviser and Broker: VSA Capital Limited Andrew Raca – Corporate Finance Andrew Monk – Corporate Broking	+44 (0) 20 3005 5000
IFC Advisory (Financial PR) Graham Herring Tim Metcalfe Florence Chandler	+44 (0) 20 3934 6630

 

About S-Ventures

S-Ventures is listed on UK AQUIS Exchange (Ticker Code "SVEN"). The Company seeks to identify investment opportunities in the health & wellness, organic food and wellbeing sectors within the UK and Europe, adding value by providing capital and expertise to the target companies. The experience and operational skills of the Board led by Scott Livingston (CEO) are intended to act as an accelerator to smaller brands that have a solid foundation and platform but may lack the skills and capital. The main objectives are to cross-fertilise opportunities between the target companies and scale the individual entities and look for exit opportunities and/or synergistic collaborations through scaling we seek to create significant value for all stakeholders. Since listing on AQSE in September 2020, the Company has acquired significant interests in seven companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NEXUOASRUOURRAA

Close

×

RNS Number : 0767B

Light Science Tech. Holdings PLC

29 September 2022

 

Light Science Technologies Holdings plc

("LSTH", the "Company" or the "Group")

 

Rentokil Contract Extension and sensorGROW trials

 

· Additional orders received worth c.£500,000 from long-standing client

· Growing demand for contract electronics manufacturing services

·   Two trials secured for sensorGROW with potential roll-on subscriptions worth up to £940,000, over a three-year period

Rentokil Orders

Light Science Technologies Holdings plc (AIM: LST), the controlled environment agriculture ("CEA") technology and contract electronics manufacturing ("CEM") group, is pleased to announce that it has received an additional £500,000 in forward orders from Rentokil Initial plc ("Rentokil"), which are expected to be fulfilled between November 2022 and March 2023. These new orders are in addition to historical forward order profiles.

 

The Group's CEM division, continues to grow in line with management expectations, driven by a strong demand for UK manufacturing in response to supply chain disruption.

The CEM division formed its customer partnership with Rentokil's pest control business over 10 years ago. The relationship has strengthened over the years with the Group providing a growing range of products.

The Group's CEM division continues to supply products to a growing number of customers across a range of market sectors and to target larger contracts which give better visibility.

sensorGROW Update

The CEA division has signed two trial contracts for the recently launched sensorGROW product. If successful, these trials could roll into subscriptions and be worth up to £940,000 in recurring revenues over a three year period. The Group is in talks regarding a number of other trials.

 

The Group has already established a strong footprint within the CEA market and the sensorGROW product provides an additional high margin route to market. The sensorGROW product provides recurring revenues as the Company provides technology, data collection, advisory and maintenance services for clients, on a three year contracted basis.

 

sensorGROW was launched in June 2022 and its t echnology enables farmers to monitor the following key growing factors (which are known as the nine cardinals of plant life) in real-time: air speed, carbon dioxide levels, humidity, light, oxygen, plant disease, soil, temperature and water pH levels – with benefits including reductions in water usage, nutrients, fertilisers and energy while increasing yields and producing healthier crops.

 

Simon Deacon, CEO and founder of Light Science Technologies, said : "We are delighted that Rentokil has chosen to increase its forward orders with us, as it shows our commitment to quality and high levels of service. This contract demonstrates the continued demand for UK manufacture, as we see customers focus on maintaining mid-term supply chain as well as controlling costs.

 

"I am also pleased to see confirmation of several sensorGROW trial contracts and expect more to be forthcoming. This demonstrates how growers see the importance of combining intelligence and increasing productivity to maximise yields within their indoor growing environments in a time when energy efficiency is crucial."

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended).

 

For further information, please contact:

 

Light Science Technologies Holdings plc	www.lightsciencetechnologiesholdings.com
Simon Deacon, Chief Executive Officer Jim Snooks, Chief Financial Officer Andrew Hempsall, Chief Operating Officer	via Walbrook PR
Strand Hanson Limited (Nominated & Financial Adviser)	Tel: +44 (0) 20 7409 3494
Ritchie Balmer / James Harris / Rob Patrick
Turner Pope Investments (TPI) Ltd (Broker)	Tel: +44 (0) 20 3657 0050
James Pope / Andy Thacker
Walbrook PR Ltd (Media & Investor Relations)	Tel: +44 (0)20 7933 8780 or  [email protected]
Nick Rome / Paul McManus

 

About Light Science Technologies Holdings plc (www.lightsciencetechnologiesholdings.com)

 

Light Science Technologies Holdings plc is the holding company of the Group's controlled environment agriculture ("CEA") division, Light Science Technologies Ltd ("Light Science Technologies"), and its contract electronics manufacturing ("CEM") division, UK Circuits and Electronics Solutions Limited ("UK Circuits").

 

Controlled Environment Agriculture

Light Science Technologies was founded in 2019 and is the Company's grow lights and sensor technology business, providing bespoke recipes and technologies tailored to customers' needs – with key targets including indoor, vertical, glasshouses, polytunnels and medicinal farming markets. The all-in-one CEA solution will include analysing customers' crop growing requirements to provide bespoke, low-energy and sustainable equipment.

 

Market drivers include food and water shortages in many parts of the world; growing global population; UK and other government policy encouraging sustainable and efficient growth methods; increased scrutiny of the effect of food production on climate change and the continuing transition away from processed foods. 

 

Contract Electronics Manufacturing

UK Circuits is the Company's CEM focussed division, profit making with strong revenues. The Group designs, procures, and manufactures high-quality CEM products, specialising in Printed Circuit Boards, which are used in a range of sectors including audio, automotive, electronics, gas detection, lighting, pest control, telecommunications and, more recently, the CEA market.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

CNTPPUWGBUPPGBR

Close

×

RNS Number : 5341A

CML Microsystems PLC

26 September 2022

 

26 September 2022

 

CML Microsystems Plc

("CML", the "Company" or the "Group")

CML plans for new state of the art business hub at Oval Park

CML Microsystems Plc, which develops mixed-signal, RF and microwave semiconductors for global communications markets, is pleased to announce plans to create significant and sustainable employment opportunities at its current 29-acre site located at Oval Park, Maldon.

On 5 July 2022, the Company announced in its final results that its Oval Park site is designated employment land in the Maldon District Plan and part of this land is excess to CML's trading requirements, which had led the Company to sign sale contracts with two separate parties, subject to them gaining appropriate planning permission for development on approximately 13 acres of land. A series of planning applications have now been submitted to Maldon District Council to create a state-of-the-art business park hub and additionally the site will house two world leading organisations in their respective fields, Maldon Crystal Salt company and Tecniq, whose relocation to the site will provide the corner stone of the development.

The transformation of the 29-acre brownfield Oval Park site, which CML has owned for over 20 years, into an exciting new business development with spacious offices, warehousing and world-class R&D facilities is expected to bring over 200 jobs to the district by 2024 and potentially many more in the next few years.

The development of the site marks a milestone in the Group's strategy to dispose of excess land where it is in shareholders' interests to do so.

Subject to planning permission, work is due to start on the site in 2023.

Nigel Clark, Chairman of CML Microsystems commented :

"The creation of a state of the art business park coupled with the relocation of the Maldon Salt Company and Tecniq, two world leading organisations in their respective fields, co-locates a trio of quality British companies providing the corner stone of the development – the best of British. The development of the Business Park provides other organisations the opportunity to join us and locate to Oval Park, attracting further investment into the Maldon District whilst also providing local companies the opportunity to raise their profile."

 

About Maldon Salt

Maldon Salt is the UK's leading salt brand, founded in Maldon in 1882. Maldon is a Royal Warrant holding family run business, dedicated to investing in its number one asset, its people. Exporting to over 60 countries around the world, Maldon is dedicated to its CSR mission and is a World Land Trust partner. Maldon has ambitious, innovative growth plans and has produced successful, sustainable year and year growth.

About Tecniq

Tecniq is a world class design and technology lead manufacturing company, with a 20-year pedigree working for car manufacturers worldwide, including Aston Martin, Bentley, Porsche Singer and Tesla. Tecniq is proud of its global reputation for combining creativity, innovation and craftmanship. Tecniq has grown rapidly in the past six years and is looking to grow its team to over 200 people by the end of 2022, including by investing in training and apprenticeships for current and new workers and is currently working alongside the University of East Anglia on graduate placements.

 

CML Microsystems Plc Chris Gurry, Group Managing Director Nigel Clark, Executive Chairman	www.cmlmicroplc.com   Tel: +44(0)1621 875 500
Shore Capital (Nominated Adviser and Broker) Advisory Toby Gibbs James Thomas John More  Corporate Broking Fiona Conroy	Tel: +44(0)20 7408 4090
Alma PR Josh Royston Andy Bryant Matthew Young	Tel: +44 (0)20 3405 0212

 

About CML Microsystems PLC

CML develops mixed-signal, RF and microwave semiconductors for global communications markets. The Group utilises a combination of outsourced manufacturing and in-house testing with trading operations in the UK, Asia and USA. CML targets sub-segments within Communication markets with strong growth profiles and high barriers to entry. It has secured a diverse, blue chip customer base, including some of the world's leading commercial and industrial product manufacturers.

The spread of its customers and diversity of the product range largely protects the business from the cyclicality usually associated with the semiconductor industry. Growth in its end markets is being driven by factors such as the appetite for data to be transmitted faster and more securely, the upgrading of telecoms infrastructure around the world and the growing prevalence of private commercial wireless networks for voice and/or data communications linked to the industrial internet of things (IIoT).

The Group is cash-generative, has no debt and is dividend paying.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

UPDSEAFMLEESEDU

Close

×

RNS Number : 0577A

Dev Clever Holdings PLC

21 September 2022

 

RNS REACH

 

 

Dev Clever Holdings plc

 

("Dev Clever", the "Group" or the "Company")

 

Launch of CSMP for Launchmycareer

 

Dev Clever (LSE: DEV), a leading developer of online and immersive career guidance, learning and development platforms, is pleased to announce that it will be exhibiting at DIDAC, Asia's largest education conference and exhibition held at Bangalore, India where it will unveil further progress on its Launchmycareer ("LMC") platform with the launch of its Career Success Membership Program ("CSMP").

 

DIDAC – this year being held from 21-23 September – showcases the latest trends in the education industry and aims to evoke a healthy discussion around the reshaping of career guidance to enable educational institutions to keep up with the rapid advancements in the sector.

Dev Clever's CSMP brings a tech-driven roadmap that weaves career-readiness into the educational framework in an age-appropriate manner. The Company's LMC experts and career counsellors will participate in the exhibition via workshops, panel discussions, and talks focused on career guidance, emphasising the need to address the employability gap with skills development.

In addition to the launch of CSMP, Dev Clever's LMC representatives will be exhibiting and showcasing its new membership card that can be purchased in bulk by schools enrolled in the CSMP to distribute to their students. Through the card, students will be able to access careers counselling and assistance, have unlimited access to careers databases, and gain exclusive access to the world's first careers metaverse. Dev Clever will also partner with third party businesses, such as retailers and brands, to enable card users to be incentivised with relevant discounts and rewards for their use of the card.

 

Through its existing network and relationships with schools in India, Dev Clever has been pre-marketing the CSMP and its membership cards to a limited number of schools. This has resulted in pre-orders for over 5,000 subscriptions reflecting the Company's already strong positioning ahead of the national Indian rollout of LMC this October.

 

Ankur Aggarwal and Chris Jeffries, Joint CEOs of Dev Clever, commented:

 

"We are thrilled to have received such a positive response to CSMP and the membership card so far and look forward to their formal unveiling at DIDAC. We could not have asked for a better launch pad than this exhibition. The world of career development is undergoing enormous change and institutions, educators, counsellors, and thought leaders must come together to provide opportunities for students to better prepare for the world of work. With the launch of CSMP and the membership card, we are one step closer to this vision of helping students become future-ready." 

 

-Ends-

 

For more information:

 

Dev Clever Holdings plc Christopher Jeffries Joint Chief Executive Officer and Executive Chairman   Ankur Aggarwal Joint Chief Executive Officer   Nicholas Ydlibi Chief Financial Officer	+44 (0) 1827 930 408
Novum Securities Limited – Financial Adviser & Joint  Broker Colin Rowbury David Coffman	+44 (0) 20 7399 9400
finnCap Limited – Joint Broker Jonny Franklin-Adams / Abigail Kelly / George Dollemore (Corporate Finance) Richard Chambers / Harriet Ward (ECM)	+44 (0) 20 7220 0500
Buchanan Communications Chris Lane / Kim van Beeck / Toto Berger	+44 (0) 207 466 5105

 

 

 

 

 

Notes to Editors:

 

About Dev Clever

Dev Clever Holdings plc, together with its wholly owned subsidiaries, is a software and technology group based in Stafford, United Kingdom, and Noida, India, specialising in the use of lightweight integrations of cloud-based VR and gamification technologies to deliver rich customer engagement experiences across both the education and commercial sectors. In January 2019, Dev Clever listed on the Standard List of the London Stock Exchange. The Group's core focus is the development and commercialisation of its core Educate platforms.

 

Dev Clever aims to reduce the global skills shortage by delivering an enhanced careers guidance service via its online platforms, Launchmycareer.com and Launchyourcareer.com, and virtual reality software (Victar VR). The business has established a global partnership with Lenovo to roll out its service worldwide, with offerings already on the market in the UK, US, and Canada. Dev Clever is also focused on the Indian market and has partnered with the National Independent Schools Alliance (NISA) to provide a comprehensive service offering within Indian budget private schools. Through this, the business has been developing and has launched a direct-to-consumer offering in India.

 

For further information, please visit  www.devcleverholdingsplc.com

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NRABKKBKFBKDDCB

Close

×

RNS Number : 9262Z

Osirium Technologies PLC

20 September 2022

 

20 September 2022

 

Osirium Technologies plc

("Osirium" or the "Group")

 

Significant contract extension

 

Osirium PAM commitment extended for a further three years

 

Osirium Technologies plc (AIM: OSI.L), a leading vendor of cloud-based cybersecurity and IT automation software, is pleased to announce that it has agreed a three-year Privileged Access Management ("PAM") licence extension with an existing customer (the "Customer"), a leading provider of IT services to local and national government in the UK.

 

The Customer initially purchased Osirium PAM in 2019 and rapidly grew from 250 to 2,600 licenses within the first year. The Customer has now decided to renew their commitment to Osirium PAM for another three years in a contract with a total value over £290k.

 

In line with the Group's SaaS business model, the full licence fee is payable at the outset and will be reflected in bookings and cash in the current financial year, with revenue being recognised over the three-year term, further underpinning management expectations for the current year.

 

David Guyatt, Chief Executive Officer, commented:

 

"We are delighted to have agreed this three-year extension, reflecting the ongoing value and importance of privileged security to our customers when cyber-attacks have never been more prolific.

 

"In line with our land-and-expand strategy, we continue to focus on increasing contract values, product take-up and device numbers with our existing customers alongside new customer acquisition."

 

 

Contacts:
Osirium Technologies plc	Tel: +44 (0)1183 242 444
David Guyatt, CEO
Rupert Hutton, CFO
Allenby Capital Limited (Nominated adviser and broker)	Tel: +44 (0)20 3328 5656
James Reeve / George Payne (Corporate Finance)
Tony Quirke (Sales and Corporate Broking)
Alma PR (Financial PR adviser)	Tel: +44 (0)20 3405 0205
Hilary Buchanan	[email protected]
Kieran Breheny
William Ellis Hancock

 

About Osirium Technologies Plc

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain.

 

With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to trading on AIM in April 2016. For further information please visit www.osirium.com .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

CNTBKCBDABKDPCD

Close